International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Market Cap	10.03B
Revenue (ttm)	326.74M
Net Income (ttm)	132.03M
Shares Out	14.93M
EPS (ttm)	8.84
PE Ratio	75.99
Forward PE	n/a
Dividend	8.65 (1.29%)
Ex-Dividend Date	n/a

Volume	90
Average Volume	778
Open	666.00
Previous Close	673.50
Day's Range	666.00 - 674.00
52-Week Range	601.00 - 1,250.00
Beta	0.21
RSI	38.85
Earnings Date	Jul 25, 2025

About Instructure Holdings

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a personal stem cell storage bank in Russia. The company is involved in the personal storage of stem cells and development of drugs for the treatment of blood and immune system diseases. It stores biomaterial samples in its database for long-term personal storage, including samples of hematopoietic cord blood stem cells, as well as samples of mesenchymal stem cells and umbilical cord tissue for transplant. The company was founded in 20...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2003
• Employees: 15
• Stock Exchange: Moscow Stock Exchange
• Ticker Symbol: GEMA

Financial Performance

In 2023, MOEX:GEMA's revenue was 283.51 million, an increase of 11.32% compared to the previous year's 254.68 million. Earnings were 125.78 million, an increase of 28.13%.